[Research progress on pyroptosis and cardiovascular diseases]

Area of Science:

• Cardiovascular Biology
• Cell Death Mechanisms
• Inflammation Research

Background:

• Pyroptosis is programmed cell death involving Gasdermin proteins and caspases, releasing inflammatory factors.
• Key molecules like NLRP3, caspases, Gasdermin D (GSDMD), and IL-1β are implicated in cardiovascular disease pathogenesis.
• Pyroptosis contributes to inflammatory responses and cell damage in cardiovascular conditions.

Purpose of the Study:

• To review the role of pyroptosis in various cardiovascular diseases.
• To summarize therapeutic strategies targeting pyroptosis for cardiovascular conditions.
• To provide a basis for clinical prevention and treatment of cardiovascular diseases.

Main Methods:

• Literature review focusing on pyroptosis and cardiovascular diseases.
• Analysis of the involvement of pyroptosis pathways in atherosclerosis, myocardial infarction, and other cardiac conditions.
• Synthesis of current research on pyroptosis-targeting treatments.

Main Results:

• Pyroptosis plays a significant role in atherosclerosis, coronary heart disease, myocardial infarction, diabetic cardiomyopathy, and cardiac hypertrophy.
• Inflammatory mediators released during pyroptosis exacerbate cardiovascular damage.
• Targeting pyroptosis presents a promising therapeutic avenue for cardiovascular diseases.

Conclusions:

• Pyroptosis is a critical mechanism in the development and progression of cardiovascular diseases.
• Modulating pyroptosis offers potential for novel therapeutic interventions.
• Further research into pyroptosis pathways can advance the clinical management of heart conditions.